Sahin is now the 493rd-richest person on the planet with a net worth of $5.1 billion. Talking about his net worth, Ugur Sahin has an estimated net worth of about $4.2 billion as of 2020. Michael Motschmann has served as a member of our Supervisory Board since 2008. BioNTech, which Dr. Sahin founded with his wife, Dr. Özlem Türeci, was mostly focused on cancer treatments. BioNTech co-founder and CEO Prof. Dr. Ugur Sahin and his wife Dr. Özlem Türeci, who saved lives with the vaccine they developed in the coronavirus (Covid-19) pandemic, were awarded the Order of Merit of the Federal Republic of Germany. Company founder […] A German citizen, Dr. Poetting holds a Master of Science in Optical Sciences from the University of Arizona and a Ph.D. in Physics from the Ludwig-Maximilians University in Munich. Also devoted to cancer and immunology research, it has helped many patients and the entire human community to fight diseases and maintain their immunity. Özlem Türeci, M.D., Co-Founder and Chief Medical Officer of BioNTech, is a physician, immunologist, and cancer researcher with translational and clinical experience. Ugur Sahin, cofondateur et dirigeant de BioNTech d’origine turque, a déclaré auprès de Reuters être optimiste sur le fait que le vaccin pourra offrir une protection face au COVID-19 pendant au moins un an. | ANDREAS ARNOLD / AFP . Mr. Jeggle has a degree in business administration from the University of Applied Sciences Neu-Ulm and earned his Master of Business Administration from the Stuttgart Institute of Management and Technology. Dr. Sierk Poetting is our Chief Financial Officer and Chief Operating Officer. “Even though this new variant has multiple mutations, only one percent of this protein is changed. Prof. Dr. Ugur Sahin, CEO, Sean Marett, CBO & CCO, Dr. Sierk Poetting, CFO & COO, PD Dr. Özlem Türeci, CMO, Ryan Richardson, CSO. In reports in the “Süddeutsche Zeitung” and ARD this week, he was accused of initially asking a price of 54 euros for a vaccine dose with a purchase of 500 million doses. Ben Stupples 4 December, 2020 12:52 pm IST. Commercial Register. BioNTech co-founder and CEO Prof. Dr. Ugur Sahin and his wife Dr. Özlem Türeci, who saved lives with the vaccine they developed in the coronavirus (Covid-19) pandemic, were awarded the Order of Merit of the Federal Republic of Germany. BioNTech founder Ugur Sahin joins world’s 500 richest after UK approves Covid vaccine BioNTech’s shares have jumped almost 8% this week and are up more than 250% for the year. Nov. 10, 2020; Leer en español Lire en français. Türeci has helped lead the discovery of cancer antigens, the development of mRNA-based individualized and off-the-shelf vaccine candidates and other types of immunotherapies which are currently in clinical development. Prof. Huber earned his MD at the University of Innsbruck. He has successfully executed complex licensing transactions with large pharmaceutical companies, negotiated M&A transactions and raised finance from investors. Dr. Poetting started his career as a consultant with McKinsey & Company. But they soon felt restricted by the limitations of university research. March 08, 2021 07:00. Covid-19 did not yet exist. Ugur Sahin is the CEO of BioNTech SE and also a medical doctor. Founder of BioNTech SE, Ganymed Pharmaceuticals AG, Ci3 Management UG and TRON - Translationale Onkologie an der Universitätsmedizin der, Ugur Sahin … ... EMAIL ALERTS Stay on top of the issues that matter to you the most. Ugur Sahin and Özlem Türeci, the husband-and-wife dream team behind the Pfizer vaccine. Prof. Huber has since 2014 served as Chairman Emeritus of the Department of Hematology and Oncology at the Johannes-Gutenberg University Mainz. HRB 48720, Local Court Mainz VAT no. Earlier in his career, Ryan spent five years as a Management Consultant to biopharmaceutical companies in the U.S. and Europe, where he worked on a wide range of strategic and operational projects in the areas of commercial strategy, pricing and market access, new product planning, and R&D operations. De interesse van het koppel is dan ook meteen gewekt als in januari dit jaar de eerste berichten uit China binnensijpelen over een nieuw coronavirus. Turkish-German scientist Ugur Sahin is the CEO of BioNTech, a biotech firm he co-founded with his wife, Ozlem Tureci, in the central German city of Mainz in 2008. Lui, s’appelle Ugur Sahin, il a 55 ans. Türeci leads the clinical development of BioNTech’s “Project Lightspeed,” the company’s successful effort to develop and distribute an mRNA-based vaccine against COVID-19, a historic achievement completed in less than one year. Updated 11 March 2021 . Fact Check: Sahin, an immunologist and cancer researcher, and his wife Dr. Özlem Türeci, co-founded BioNTech, a German company that recently announced that it has jointly developed with Pfizer a COVID-19 vaccine, according to The Guardian.He immigrated to Germany from Turkey with his parents as a young child, The Associated Press reported. Two years ago, Dr. Ugur Sahin took the stage at … Prof. Huber was a co-founder of Ganymed, now a subsidiary of Astellas Pharma Inc. Germany, For questions on logistics, handling or other issues: service@biontech.de, For any other questions, please use our contact form at connect.biontech.de, We aspire to utilize the full potential of the immune system to fight cancer and infectious diseases, Our vision: individualize cancer medicine, Why mRNA represents a disruptive new drug class, Beyond mRNA: our antibody discovery engines, Tour our platforms of tailored therapeutics, Broadening the therapeutic universe for patients. A ce titre, la PME travaille sur la … CEO and co-founder of BioNTech, Ugur Sahin, answers journalists' questions after the European Medicines Agency approved its COVID-19 vaccine, at the company headquarters in … La technologie de l’ARN messager. Sahin’s academic credentials include serving as a Full Professor (W3) in Translational Oncology & Immunology at Johannes Gutenberg University in Mainz, Germany, where he was the supervisor for more than 50 PhD students. She currently serves as President of the Association for Cancer Immunotherapy (CIMT) in Germany. Thank heavens for people like Ugur Sahin and Ozlem Tureci. Linkedin. VU D'AILLEURS - Ugur Sahin et son entreprise BioNTech sont en tête de la course au vaccin contre le Covid-19. Ryan Richardson is our Chief Strategy Officer. Ugur Sahin, the founder of the vaccine company Biontech, is now defending himself against the accusation that he set too high a price for the corona vaccine. Le monde a découvert que ses cofondateurs, Ugur Sahin et Özlem Türeci, un couple de médecins-chercheurs, sont des enfants d’immigrés turcs au parcours exceptionnel. This information is derived from proxy statements filed for the 2019 fiscal year.. Coronavirus : Pfizer annonce un vaccin efficace à plus de 90%, les Bourses flambent. Ugur Sahin, le cofondateur de BioNTech, en novembre 2019. Ugur Sahin, the co-founder and chief executive of BioNTech, the firm which developed the earliest authorized vaccine in partnership with Pfizer, told Arab News that successful cancer treatment, using similar techniques he developed in the fight against COVID-19, was his next goal. Under the terms of the second agreement, the companies will deliver at least 70 million of the additional doses by June 30, 2021, with the remaining 30 million doses to be delivered no later than July 31, 2021. Email. He holds a BSc (Hons) in Biochemistry from Kings College London and an MBA from Manchester Business School. Ugur Sahin, BioNTech CEO ... BioN­Tech chief Ugur Sahin gains star sta­tus in the ex­clu­sive Cov­il­lion­aire club. He has pioneered several breakthroughs enabling the development of mRNA vaccines and other types of immunotherapies. Dr. Poetting joined BioNTech in September 2014 from Novartis, where he served from May 2012 to August 2014 as Vice President and Chief Financial Officer for the Sandoz Division in North America. Het vaccin van BioNTech en Pfizer is op dit moment het enige dat goedgekeurd is in de Europese Unie waardoor een enorm veel vraag is. Email Heroes of our time. Mr. Marett has been Chairman of PHMR Ltd, a company specializing in market access and pharmaceutical reimbursement, since 2017. The co-founder of BioNTech SE on Thursday joined the world’s 500 richest people after the U.K. this week approved use of a Covid-19 vaccine that the German firm created with Pfizer Inc. Avec sa femme, ce fils d'immigrés turcs a mis sur pied un incroyable centre de commande. Ugur Sahin met her when she was a young doctor at the university hospital in Homburg, Saarland. Prof. Christoph Huber, MD is a co-founder of BioNTech and has served as a member of our Supervisory Board since 2008. Mr. Motschmann co-founded MIG Verwaltungs AG, or MIG, in 2004, where he serves on the Management Board and as Head of Equity Investments. John Carroll ... We'll e-mail you a link to set a new password. Ugur Sahin made $7,064,000 in total compensation as Chief Executive Officer at BioNTech in 2019.$311,000 was received as Total Cash, $6,748,000 was received as Equity and $5,000 was received as Pension and other forms of compensation. By David Gelles. “He wants to carry out cancer research in Turkey. Ugur Sahin llegó a Alemania procedente de Turquía cuando era niño, pero esta foto no corresponde a su familia. Twitter. Ryan holds an MBA from the University Of Chicago Booth School Of Business, an MSc from the London School of Economics, and a BS in Biology from the University of Kansas. The company was acquired by Astellas in 2016. © Copyright BioNTech SE 2021. Dr. Wandschneider has more than 20 years of experience in the healthcare sector as a manager in the operative business and as a member of boards and committees. E-Mail: service@biontech.de. Frankly Speaking | S1 E9 | Ugur Sahin Founder and CEO of Biontech. Mr. Marett built and ran a contract clinical manufacturing organization with operations across Europe and the United States for over half a decade for the contract manufacturer, NextPharma. Wie wirksam kann er voraussichtlich sein? Husband and wife, they’re cofounders of BioNTech … For U.S. Investors: Westwicke John Woolford Send Email +1 443 213-0506. Competent Authority. : +49 6131 9084-0E-Mail: service@biontech.de, Prof. Dr. Ugur Sahin, CEO,Sean Marett, CBO & CCO,Dr. Germany, For questions on logistics, handling or other issues: service@biontech.de, For any other questions, please use our contact form at connect.biontech.de, We aspire to utilize the full potential of the immune system to fight cancer and infectious diseases, Our vision: individualize cancer medicine, Why mRNA represents a disruptive new drug class, Beyond mRNA: our antibody discovery engines, Tour our platforms of tailored therapeutics, Broadening the therapeutic universe for patients. She is a recent recipient of the German Sustainability Award, among other notable recognitions. Voici l’histoire du couple de chercheurs allemands d’origine turque, Ugur Sahin et Özlem Türeci, qui ont fondé en 2008 la société BioNTech. Furthermore, the company can also make the mutation-beating vaccine in six weeks. Represented by the Management Board. The co-founder of BioNTech SE on Thursday joined the world's 500 richest people after the U.K. this week approved use … Prof. Ugur Sahin, M.D., Co-Founder and CEO of BioNTech, is a physician, immunologist and leader in the development of novel approaches to fight cancer and infectious diseases. He also leads BioNTech’s research and development of neoantigen specific mRNA cancer vaccines which are individually tailored and produced on demand according to the profile of non-synonymous mutations identified by next-generation sequencing in patients’ tumors. Chief Business and Chief Commercial Officer. Mr. Jeggle is currently also the Managing Director of Salvia GmbH (since 2014), where he is acting as a Business Angel. © Copyright BioNTech SE 2021. BioNTech vaccine inventors to receive Germany's Knight Commander's Cross. Sahin initiated and oversees “Project Lightspeed,” the historic development of the first mRNA vaccine for COVID-19, moving from lab and clinical testing to conditional approval within an unprecedented 11-month period. BioNTech et Pfizer travaillent également sur "de nouvelles formules qui pourraient rendre notre vaccin encore plus facile à transporter et utiliser", a ajouté Ugur Sahin. Uğur Şahin ([uːɾ ʃaː.hin]; born September 29, 1965) is a German oncologist and entrepreneur and founder of BioNTech, who helped develop one of the major vaccines against COVID-19. WhatsApp. The co-founder of BioNTech SE on Thursday joined the world's 500 richest people after the U.K. this week approved use of a … All Rights Reserved. Based on his contributions to scientific discovery, Dr. Sahin has received numerous awards and recognitions, including the German Sustainability Award, the Mustafa Prize, and the German Cancer Award. In reports in the “Süddeutsche Zeitung” and ARD this week, he was accused of initially asking a price of 54 euros for a vaccine dose with a purchase of 500 million doses. The CEO of BioNTech Ugur Sahin is a married man and has a wife. Mr. Jeggle has been the Managing Director and Chief Operating Officer of ATHOS Service GmbH since 2015. BioNTech SEAn der Goldgrube 1255131 MainzGermany, Tel. Sean Marett joined BioNTech in 2012. Begin januari is daar meer duidelijkheid over, zegt BioNTech-topman Ugur Sahin maandag tegen het Duitse persbureau DPA. BioNTech SE Ugur Sahin is co-inventor of more than 500 filed patents applications and patents. BioNTech chief executive Professor Ugur Sahin acknowledged governments have difficult decisions to make with limited supplies of the vaccine, but he added that there needs to be recognition of the limited protection provided by just one dose It had never brought a product to market. Sierk Poetting, CFO & COO,PD Dr. Özlem Türeci, CMO,Ryan Richardson, CSO, HRB 48720, Local Court MainzVAT no. Ugur Sahin (pictured with wife and fellow board member Ozlem Tuereci), CEO and founder of BioNTech has seen his personal fortune increase by … Share on WhatsApp . Pfizer and BioNTech have increased manufacturing capacity to more than 2 billion doses a year from 1.3 billion to meet demand, BioNTech Chief Executive Ugur Sahin said. Helmut Jeggle. Ook BioNTech focust zich in eerste instantie op immuuntherapie tegen kanker, maar die methode zou volgens Şahin en Türeci ook kunnen werken om virussen en bacteriën te kunnen bestrijden. Uğur Şahin, né le 12 septembre 1965 en Turquie, à Alexandrette, est un médecin et chef d'entreprise allemand.Il est depuis 2006 professeur d'oncologie à la 3 e clinique médicale de l'université Johannes-Gutenberg de Mayence.Il a créé la société de biotechnologie BioNTech … Volgens Ugur Sahin, CEO van BioNTech zal het aanbod echter schaars blijven tot andere coronavaccins goedgekeurd zijn. Following is the unofficial transcript of a CNBC EXCLUSIVE interview with BioNTech CEO Dr. Ugur Sahin on CNBC's "Squawk Box" (M-F, 6AM-9AM ET) … He has pioneered several breakthroughs enabling the development of mRNA vaccines and other types of immunotherapies. BioNTech, a company founded in 2008 by the German scientists and married couple Şahin and Özlem Türeci, as well as the Austrian oncologist Christoph Huber, developed its … Send Email +49 6131 9084-0. Ugur Sahin a fondé BioNTech avec son épouse, Oezlem Tuereci, qui est le médecin en chef de la société. BioNTech SE Chief Executive Officer Ugur Sahin, the researcher behind one of the first approved coronavirus vaccines. From 2002 until 2007, Mr. Jeggle held various positions with Hexal AG, including Head of Business Planning & Analyses. Landesamt für Soziales, … Ulrich Wandschneider, PhD, has served as a member of our Supervisory Board since 2018. Facebook. He is a member of numerous supervisory boards, including 4SC AG. Both were moved by the question of how to cure cancer. Ugur Sahin just reached another milestone. Die beiden Wissenschaftler und Biontech-Gründer Özlem Türeci und Ugur Sahin haben in Berlin das Bundesverdienstkreuz erhalten. From 2011 to 2018 Dr. Wandschneider initially served as Chief Executive Officer of Asklepios Kliniken GmbH & Co. KGaA and afterwards as Chairman of the Board. The recent news relating to Ugur Sahin has been all over the internet which stated that the US firm Pfizer and the German company BioNTech and have proven the vaccine to be 90% effective in preventing … In his role with MIG, Mr. Motschmann currently serves on the supervisory boards of several private portfolio companies. Our goal remains to bring a safe and effective COVID-19 vaccine to as many people as we can all around the world,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. Bundespräsident … 55131 Mainz He brings more than 15 years of experience in the finance and healthcare industries to BioNTech. “Una familia de inmigrantes musulmanes turcos llegaba a Alemania. Now the company is reporting a breakthrough. Photos: BioNTech SE 2020. “Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant,” said Ugur […] Avec Borsarama Following is the unofficial transcript of a CNBC EXCLUSIVE interview with BioNTech CEO Dr. Ugur Sahin on CNBC's "Squawk Box" (M-F, 6AM-9AM ET) … : DE 263 382 495, Landesamt für Soziales, Jugend und VersorgungRheinallee 97-10155118 MainzGermany, BioNTech SE Ozlem, like her husband, is also a businessperson, immunologist, and physician. Prior to joining BioNTech in 2018 as SVP Corporate Development & Strategy, Ryan was an Executive Director in the Global Healthcare Investment Banking team at J.P. Morgan in London, where he advised companies in the biotech and life sciences industry on M&A, equity and debt capital financings.